货号:A230954
同义名:
EVP4593; CAY10470
QNZ(EVP4593)对NF-κB转录激活和TNF-α生成具有强效抑制作用,IC50值分别为11 nM和7 nM。QNZ(EVP4593)是一种神经保护性的SOC通道抑制剂。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | TNF-α ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thalidomide | ✔ | E3 Ligase | 98% | ||||||||||||||||
| GSK2982772 |
++
human RIP1, IC50: 16 nM |
99%+ | |||||||||||||||||
| QNZ |
++++
TNF-α, IC50: 7 nM |
NF-κB | 99%+ | ||||||||||||||||
| Lenalidomide |
+++
TNF-α, IC50: 13 nM |
99% | |||||||||||||||||
| Pomalidomide |
+++
TNF-α, IC50: 13 nM |
98% | |||||||||||||||||
| GSK481 | ✔ | 99%+ | |||||||||||||||||
| Apremilast |
++
TNF-α, IC50: 77 nM |
98% | |||||||||||||||||
| Necrostatin-1 |
+
RIP1, EC50: 490 nM |
99%+ | |||||||||||||||||
| Acetylcysteine | ✔ | 98% | |||||||||||||||||
| Adalimumab | ✔ | 98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Nuclear factor-κB (NF-κB) is a protein complexes which is a pivotal transcription factor. It involves in regulating the immune system by enhancing the transcription of proinflammatory cytokines in the generation of acute inflammatory responses[1]. QNZ is a potent and selective NF-κB inhibitor with IC50 value of 11 nM[2]. SK-HEP-1 cells were treated with 0.4 µM QNZ and the cell viability measured by MTT assay was significantly inhibited in a time dependent manner. The NF-κB p65 (Ser536), anti-apoptotic proteins (XIAP, MCL-1 and c-FLIP) level examined by western blotting assay also inhibited after 48 hours of treatment[3]. BALB/c mice with infection in the right hind paw were i.p. injected with 0.001 g/kg of QNZ and 0.1 g/kg glucantime for five consecutive days. The combined treatment could decrease the lesion sizes of the infected paws significantly compared with the control group and increase IL-1β production in the supernatant from the excised infected paws measured by ELISA[4]. |
| 作用机制 | QNZ inhibited the activation of NF-κB through inhibiting the phosphorylation of the its subunit IκBα and block the nuclear translocation of NF-κB[5][6]. |
| Concentration | Treated Time | Description | References | |
| macrophages | 20 nM | to study the effect of QNZ on the NFκB signaling pathway in macrophages | Front Immunol. 2017 Sep 4;8:1063. | |
| SW620 cells | 10 nM | QNZ decreased the expression of CCL20 in SW620 cells | J Immunother Cancer. 2019 Aug 8;7(1):215. | |
| DLD-1 cells | 10 nM | QNZ decreased the expression of CCL20 in DLD-1 cells | J Immunother Cancer. 2019 Aug 8;7(1):215. | |
| BM-LCs | 10 μM | 2 h | To detect the effect of IL-38 on CCR7 expression in BM-LCs. The results showed that QNZ pretreatment could inhibit the upregulation of CCR7 expression induced by IL-38. | Int J Biol Sci. 2024 May 27;20(8):3094-3112. |
| BMDCs | 80 μg/mL | 22 h | To verify whether QNZ affects BMDC maturation by inhibiting the NF-κB signaling pathway. The results showed that pretreatment with QNZ significantly inhibited KK2DP7-induced BMDC maturation. | Adv Sci (Weinh). 2023 May;10(15):e2300116. |
| BV2 microglial cells | 10 µM | 24 h | QNZ significantly suppressed the inhibitory effect of 2.5 µM EC on the expression of iNOS | Molecules. 2019 Sep 12;24(18):3317. |
| HaCaT cells | 5 μM | QNZ alone significantly inhibited cell proliferation and induced apoptosis, and no additional effect on inhibiting cell proliferation or inducing apoptosis was observed when combined with BIX01294. | Cell Death Dis. 2023 Sep 22;14(9):627. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | DNFB-induced AD model | Transdermal administration | 2 mg/kg | From day 6 until the end of modelling | QNZ alleviated DNFB-induced AD symptoms by inhibiting the NF-κB signaling pathway | Int J Biol Sci. 2024 May 27;20(8):3094-3112. |
| Dose | Mice: 1 mg/kg[7] (i.p.) |
| Administration | i.p. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.81mL 0.56mL 0.28mL |
14.03mL 2.81mL 1.40mL |
28.06mL 5.61mL 2.81mL |
|
| CAS号 | 545380-34-5 |
| 分子式 | C22H20N4O |
| 分子量 | 356.42 |
| SMILES Code | NC1=CC2=C(NCCC3=CC=C(OC4=CC=CC=C4)C=C3)N=CN=C2C=C1 |
| MDL No. | MFCD06411436 |
| 别名 | EVP4593; CAY10470 |
| 运输 | 蓝冰 |
| InChI Key | IBAKVEUZKHOWNG-UHFFFAOYSA-N |
| Pubchem ID | 509554 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 35 mg/mL(98.2 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1